6 views
# Cardio Balance best medicine against high blood pressure # :::warning Kasabay nito, hindi inirerekomenda ang pangmatagalang pag-inom ng mga gamot mula sa kategoryang Diuretics, dahil ang mahahalagang sangkap tulad ng Potassium, Calcium, Magnesium ay mabilis na nailalabas sa katawan kasama ng sobrang tubig at asin. Alinsunod sa katangiang ito, sinasabayan ng mga Diuretics ang pag-inom ng mga gamot na may laman ng mga sangkap na ito. Maaaring ito ay mga vitamin at mineral na complexes, monokomponent, o mga suplemento sa pagkain na may napatunayang klinikal na bisa. ::: [![](https://cardio-balance-ph.store-best.net/img/3.jpg)](https://cardio-balance-ph.store-best.net) <div style="height:500px;"></div> ## Non-modifiable risk factors for cardiovascular diseases ## <div class="alert alert-info" role="alert"> Ektrak mula sa prutas ng cranberry Ektrak mula sa prutas ng appleberry Magnesium L-Arginin Ektrak mula sa dahon at bulaklak ng hawthorn Pulbos ng bulaklak ng hibiscus Ektrak mula sa dahon ng oliba Ektrak mula sa buto ng ubas Ektrak mula sa black currant Coenzyme Q10 Bitamina B6 Folate </div> Of course! Here is a scientific Text is in German on the subject of Edarbi as an effective drug against high blood pressure: Edarbi: A modern approach to the therapy of arterial hypertension The arterial hypertension (high blood pressure) is a global health problem and is considered to be one of the main risk factors for cardiovascular disease, including heart attack, stroke, and congestive heart failure. The effective reduction in blood pressure is, therefore, of crucial importance for the prevention of these life-threatening complications. In this context, Edarbi (active ingredient: Azilsartan medoxomil) has established itself as a highly effective and safe drug for the long-term treatment of hypertension. Pharmacological Mechanism Of Action Edarbi belongs to the class of Angiotensin II receptor antagonists (AT1‑receptor blocker). The active ingredient Azilsartan medoxomil selectively inhibits the binding of Angiotensin II to its AT1 receptors, the vessels mainly in the blood, heart, and kidneys are located. Through this inhibition, the following effects can be achieved: Vasodilation (Vascular Dilation), Reduction in Aldosterone secretion, Decrease of peripheral vascular resistance, Lowering of blood pressure. In comparison to other AT1 receptor blocker Azilsartan shows a particularly strong and long-lasting binding to the receptors, which leads to a stable blood pressure control over 24 hours. Clinical Efficacy Several randomized controlled trials (RCTs) have demonstrated the efficacy of Edarbi in patients with mild-to-moderate hypertension. In a pivotal study, it was shown that a daily dose of 40 mg or 80 mg Azilsartan medoxomil leads to a significant reduction in both systolic and diastolic blood pressure, compared to Placebo and other antihypertensive drugs such as Valsartan or Olmesartan. Particularly, the effectiveness is emphasized in patients who do not respond to other AT1‑Blocker inadequate. Edarbi also shows in elderly patients and in patients with metabolic syndrome have a good efficacy and tolerability. Safety and tolerability In clinical studies, Edarbi showed a favorable safety profile. The most common side effects were: Headache, Dizziness, Fatigue, slight hypotension. However, these effects occur are usually mild and rarely lead to discontinuation of therapy. Compared to ACE inhibitors (e.g. Ramipril) gives Edarbi no irritating cough, which improves the long-term patient compliance significantly. Dosage and administration Diefangsdosis is 40 mg once a day. In case of insufficient reduction in blood pressure, the dose can be increased to 80 mg/day. Edarbi, regardless of the meals. In patients with moderate renal impairment no dose adjustment is required; in the case of severe kidney or liver disease, the therapy should be carried out with particular caution. Conclusion Edarbi (Azilsartan medoxomil), due to its high effectiveness, long-lasting effect and good tolerability is a valuable adjunct in the therapy of arterial hypertension. It is, in particular, patients who do not respond to other antihypertensives inadequate or side effects, offers an effective Alternative. An individual Benefit-risk assessment by the attending physician, however, is always required. If you want, I can customize the Text, cut or other aspects (e.g., direct comparisons with other drugs, long-term data, cost‑Benefit considerations), complement! > Una sa lahat, ang mga Beta-blocker ay karaniwang ibinibigay sa mga pasyente na may heart failure, aortic aneurysm, pagkatapos ng myocardial infarction, at sa mga kababaihan na nasa edad ng pagbubuntis, lalo na sa mga kababaihang nagpaplano ng pagbubuntis. Madalas matanggap ng katawan ang Beta-blocker, pero maaari rin itong magdulot ng pantal sa balat at bradycardia – sobrang bagal ng tibok ng puso. ![](https://cardio-balance-ph.store-best.net/img/8.jpg) <a href="https://doc.interscalar.eu/s/2EbpANwhh">Hypertensive heart disease cardiovascular disease</a> Constant high levels of stress can disturb the blood flow and blood pressure and can damage vessels, and you may experience dizziness, extreme fatigue, or body aches with no wish to get out of bed. This stress-induced fatigue can make your blood pressure high and needs to be monitored. <a href="https://pads.tobast.fr/s/jYuIEwHmC6">https://pads.tobast.fr/s/jYuIEwHmC6</a> ## Hypertensive heart disease cardiovascular disease ## Hypertensive heart disease as part of the cardiovascular diseases The hypertensive heart disease (also hypertensives heart called) represents an important subgroup of cardiovascular disease (CVD) and is associated directly with the essential hypertension. This disease develops due to a persistently elevated blood pressure that causes a chronic Overload of the heart muscle. Pathophysiology The Central mechanism of the hypertensive heart disease, left ventricular hypertrophy (LVH) is. Because of the increased peripheral resistance the left ventricle must work harder to pump the blood into the General circulation. This leads to a thickening of the wall of the left ventricle (ventricular wall thickness&gt;1.1 cm in the echocardiogram). First of all, this adaptation acts as a compensatory mechanism, in the long term, however, it reduces the elastic capacity of the heart and leads to diastolic dysfunction. Further pathophysiological changes include: Fibrosis of the myocardium; Vascular Lesions (Atherosclerosis); Disorders of the coronary circulation; possible Dilatation of the left atrium as a consequence of diastolic dysfunction. Risk factors Among the main risk factors for the development of hypertensive heart disease: persistent blood pressure ≥140/90 mmHg; family history; Age (particularly over 55 years in men and 65 years in women); Overweight and obesity; unhealthy lifestyle (lack of physical activity, high salt intake, alcohol, and nicotine); Diabetes mellitus; Dyslipidemia. Clinical Symptoms In the early stages of hypertensive heart disease is often asymptomatic. With the Progression of the disease, the following symptoms may occur: Exertional dyspnoea (shortness of breath during physical exertion); Fatigue (Fatigue); Angina pectoris (chest pain); Cardiac arrhythmias (e.g., atrial fibrillation); in advanced cases, signs of congestive heart failure (Edema of the lower extremities, hepatomegaly). Diagnostics The diagnosis includes a combination of different methods: Blood pressure measurement (the best 24‑hour blood pressure monitoring); Echocardiography (evidence of LVH, assessment of systolic and diastolic function); Electrocardiogram (signs of LVH: high QRS amplitude in the precordial leads); Laboratory Tests (Kidney Function, Lipid Spectrum Of Blood Sugar); if necessary, stress testing or coronary angiography for suspected coronary heart disease. Therapy The main goal of the therapy is the reduction of blood pressure to below 140/90 mmHg (in diabetic patients under 130/80 mmHg) and the prevention of complications. Drug Therapy Options: ACE inhibitors (eg, Enalapril) or AT1‑receptor blockers (e.g., Losartan), show a particularly favorable effect on the Regression of LVH; Beta-blockers (e.g., Metoprolol), while heart failure or rhythm disturbances; Calcium channel blockers (e.g. amlodipine), especially in elderly patients; Diuretics (such as hydrochlorothiazide) to the volume reduction. Non-Pharmacological Measures: Weight reduction; Reduction of salt intake (&lt;5 g/day); regular physical activity (at least 150 minutes of moderate load per week); Waiver of Smoking and reduction of alcohol consumption; Stress management. Forecast With adequate blood pressure control and lifestyle changes, the prognosis can be significantly improved. Without therapy, hypertensive heart disease, however, leads to an increased risk for heart failure, heart attack, stroke, and sudden cardiac death. If you want, I can make certain sections in more detail, or to add more information about a specific aspect! <a href="https://notes.medien.rwth-aachen.de/s/ODcwpT7bkp">Non-modifiable risk factors for cardiovascular diseases</a> ** Cardio Balance best medicine against high blood pressure **. Non-modifiable risk factors: What you should know about your cardiovascular risk Your heart is your life the engine is, but some risk factors for cardiovascular disease do not change, you can. Knowledge is Power: you Recognize your personal risks in order to avoid this from happening! What is the non-modifiable risk factors? Age: With age, increasing your risk for heart disease-circulation. Particularly in men aged 45 years and women aged 55 years, a special attention is attached. Gender: men are generally affected earlier and more frequently from heart disease. In women, the risk increases after Menopause significantly. Family history: A history of early cardiovascular disease in the family (in men before the age of 55. Age, and in women before the age of 65. Years of age), increases your individual risk. Genetic predisposition to Certain genetic factors can influence the risk of high blood pressure, high cholesterol, or Diabetes — and thus your heart risk. The Good news: you can still do a lot for your heart! Even if these factors are not influenced, there are numerous ways to reduce your overall risk: Healthy Diet Regular physical activity Waiver of Smoking and excess alcohol consumption Control of blood pressure, blood sugar and cholesterol Stress management Keep your heart active! Use the power of prevention: Talk with your doctor about your individual risk profile and develop a tailored health plan. Your heart will thank you — every day. Arrange an appointment today for risk Advisory! - [x] <a href="https://hedgedoc.ctf.mcgill.ca/s/ALqK41MjK">Non-modifiable risk factors for cardiovascular diseases</a> - [x] <a href="https://hdoc.csirt-tooling.org/s/N9WQNnjrlp">Hypertensive heart disease cardiovascular disease</a> - [x] <a href="https://markdown.iv.cs.uni-bonn.de/s/Q1myDrj0gc">The treatment of cardiovascular diseases, Germany</a> - [x] <a href="https://hedgedoc.obermui.de/s/OgiNKySt22">https://hedgedoc.obermui.de/s/OgiNKySt22</a> <a href="https://pad.hxx.cz/s/6FFWbXSQUi">https://pad.hxx.cz/s/6FFWbXSQUi</a> <a href="https://pads.tobast.fr/s/TZ3Ja5k9su">https://pads.tobast.fr/s/TZ3Ja5k9su</a> <a href="https://hedgedoc.digilol.net/s/CL9uHUGLzK">https://hedgedoc.digilol.net/s/CL9uHUGLzK</a> <a href="https://hedgedoc.ffmuc.net/s/MfSOwPs9LK">https://hedgedoc.ffmuc.net/s/MfSOwPs9LK</a> <a href="https://md.sigma2.no/s/sWKzhtI4G">https://md.sigma2.no/s/sWKzhtI4G</a> <a href="https://hedge.grin.hu/s/86-86y2Sed">https://hedge.grin.hu/s/86-86y2Sed</a> <a href="https://pad.mytga.de/s/zIZQtHo8d">https://pad.mytga.de/s/zIZQtHo8d</a> <a href="https://doc.neutrinet.be/s/mjuvk1_6AX">https://doc.neutrinet.be/s/mjuvk1_6AX</a> <a href="https://notas.laotra.red/s/s65rxJk2Q6">https://notas.laotra.red/s/s65rxJk2Q6</a> <a href="https://hedgedoc.private.coffee/s/VAjHIdE2o">https://hedgedoc.private.coffee/s/VAjHIdE2o</a> <a href="https://pad.koeln.ccc.de/s/O8xxs5WyD">https://pad.koeln.ccc.de/s/O8xxs5WyD</a> <a href="https://hedgedoc.auro.re/s/HLo0Fk9gt1">https://hedgedoc.auro.re/s/HLo0Fk9gt1</a> <a href="https://docs.localcharts.org/s/b-n6KND_5">https://docs.localcharts.org/s/b-n6KND_5</a> <a href="https://hedgedoc.nrp-nautilus.io/s/vaTpl1hhB4">https://hedgedoc.nrp-nautilus.io/s/vaTpl1hhB4</a> <a href="https://pad.multiplace.org/s/B1cXo9uMGe">https://pad.multiplace.org/s/B1cXo9uMGe</a> <a href="https://doc.projectsegfau.lt/s/WlpVRFsqfl">https://doc.projectsegfau.lt/s/WlpVRFsqfl</a> <a href="https://md.coredump.ch/s/QVkESuJh6">https://md.coredump.ch/s/QVkESuJh6</a> <a href="https://notes.rabjerg.de/s/rkj7sqOzMg">https://notes.rabjerg.de/s/rkj7sqOzMg</a> <a href="https://pad.sra.uni-hannover.de/s/QfV7ZUOr4m">https://pad.sra.uni-hannover.de/s/QfV7ZUOr4m</a> <a href="https://doc.hkispace.com/s/AHXbSUesJ">https://doc.hkispace.com/s/AHXbSUesJ</a> <a href="https://edit.leiden.digital/s/Zl_Wub8ar3">https://edit.leiden.digital/s/Zl_Wub8ar3</a> <a href="https://md.sebastians.dev/s/Q1UaEFgKb">https://md.sebastians.dev/s/Q1UaEFgKb</a> <a href="https://doc.interscalar.eu/s/oWn-PQldh">https://doc.interscalar.eu/s/oWn-PQldh</a> <a href="https://md.mandragot.org/s/oWtRvxdsYl">https://md.mandragot.org/s/oWtRvxdsYl</a> <a href="https://hack.utopia-lab.org/s/M7tQIzzIi">https://hack.utopia-lab.org/s/M7tQIzzIi</a> <a href="https://omoffice.de/s/ByeSoquGze">https://omoffice.de/s/ByeSoquGze</a> <a href="https://md.rappet.xyz/s/1yGslBUtUu">https://md.rappet.xyz/s/1yGslBUtUu</a> <a href="https://pad.gusted.xyz/s/1tXz2BMBv">https://pad.gusted.xyz/s/1tXz2BMBv</a> <a href="https://doc.spiegie.de/s/Gkf8jbtxg">https://doc.spiegie.de/s/Gkf8jbtxg</a> <a href="https://pad.cttue.de/s/7p0jmnILa">https://pad.cttue.de/s/7p0jmnILa</a> <a href="https://pad.demokratie-dialog.de/s/6uNQbxhYcJ">https://pad.demokratie-dialog.de/s/6uNQbxhYcJ</a> <a href="https://hedgedoc.inqbus.de/s/cWPcVdQYG">https://hedgedoc.inqbus.de/s/cWPcVdQYG</a> <a href="https://pad.n39.eu/s/UfRXmvlFj8">https://pad.n39.eu/s/UfRXmvlFj8</a> <a href="https://www.notizen.kita.bayern/s/kLrOf1jrfG">https://www.notizen.kita.bayern/s/kLrOf1jrfG</a> <a href="https://hdoc.csirt-tooling.org/s/ZspVf46kLP">https://hdoc.csirt-tooling.org/s/ZspVf46kLP</a> <a href="https://hedgedoc.et.aksw.org/s/1s7LeLppt">https://hedgedoc.et.aksw.org/s/1s7LeLppt</a> <a href="https://md.nolog.cz/s/9yG3K2M-t">https://md.nolog.cz/s/9yG3K2M-t</a> <a href="https://md.globenet.org/s/Hy7v76zaR">https://md.globenet.org/s/Hy7v76zaR</a> <a href="https://doc.gnuragist.es/s/O2d2KN-Ht2">https://doc.gnuragist.es/s/O2d2KN-Ht2</a> <a href="https://doc.fsr.saarland/s/mvU9qk41zt">https://doc.fsr.saarland/s/mvU9qk41zt</a> <a href="https://md.interhacker.space/s/FkpVkMONT">https://md.interhacker.space/s/FkpVkMONT</a> <a href="https://hedgedoc.ichmann.de/s/DID19K7j11">https://hedgedoc.ichmann.de/s/DID19K7j11</a> <a href="https://doc.fung.uy/s/FThYfYWfhh">https://doc.fung.uy/s/FThYfYWfhh</a> <a href="https://doc.hkispace.com/s/O4d5GI8gM">https://doc.hkispace.com/s/O4d5GI8gM</a> <a href="https://hedgedoc.jcg.re/s/vetjex4E_q">https://hedgedoc.jcg.re/s/vetjex4E_q</a> <a href="https://pad.dominick-leppich.de/s/yoYYNGzHj">https://pad.dominick-leppich.de/s/yoYYNGzHj</a> <a href="https://pad.fablab-siegen.de/s/KpdjeyNnXf">https://pad.fablab-siegen.de/s/KpdjeyNnXf</a> <a href="https://write.frame.gargantext.org/s/r1SEt5dMzl">https://write.frame.gargantext.org/s/r1SEt5dMzl</a> <a href="https://hedgedoc.team23.org/s/m2RCLtEsko">https://hedgedoc.team23.org/s/m2RCLtEsko</a> <a href="https://doc.interscalar.eu/s/ze8F__LbH">https://doc.interscalar.eu/s/ze8F__LbH</a> <a href="https://pad.nantes.cloud/s/NV_-FlWc7k">https://pad.nantes.cloud/s/NV_-FlWc7k</a> <a href="https://pads.dgnum.eu/s/MEWOrXuQiW">https://pads.dgnum.eu/s/MEWOrXuQiW</a> <a href="https://hedgedoc.obermui.de/s/ULv8aqxAN0">https://hedgedoc.obermui.de/s/ULv8aqxAN0</a> <a href="https://md.softwarefreedom.net/s/oy6TPE_PU">https://md.softwarefreedom.net/s/oy6TPE_PU</a> <a href="https://pad.ccc-p.org/s/pqaR1VM8mL">https://pad.ccc-p.org/s/pqaR1VM8mL</a> <a href="https://notas.gaiacoop.tech/s/tWPGsq2Ni">https://notas.gaiacoop.tech/s/tWPGsq2Ni</a> <a href="https://hedge.amosamos.net/s/LZ8IXoMEz3">https://hedge.amosamos.net/s/LZ8IXoMEz3</a> <a href="https://hedgedoc.stanleysolutionsnw.com/s/Xar-tvQHeZ">https://hedgedoc.stanleysolutionsnw.com/s/Xar-tvQHeZ</a> <a href="https://notes.simeonreusch.com/s/xkROZu8Ox">https://notes.simeonreusch.com/s/xkROZu8Ox</a> <a href="https://notes.llgoewer.de/s/yjJJD_Zhu">https://notes.llgoewer.de/s/yjJJD_Zhu</a> <a href="https://md.cortext.net/s/agEkHneeH">https://md.cortext.net/s/agEkHneeH</a> <a href="https://md.gafert.org/s/E64h0W1vN">https://md.gafert.org/s/E64h0W1vN</a> <a href="https://pads.cantorgymnasium.de/s/ZODAXVOY_">https://pads.cantorgymnasium.de/s/ZODAXVOY_</a> <a href="https://doc.cisti.org/s/YtopqYtuEI">https://doc.cisti.org/s/YtopqYtuEI</a> <a href="https://pad.mytga.de/s/a_CjpgaRN">https://pad.mytga.de/s/a_CjpgaRN</a> <a href="https://codi.sevenvm.de/s/k3qOTyRO9">https://codi.sevenvm.de/s/k3qOTyRO9</a> <a href="https://dok.kompot.si/s/S4APrLQFd7">https://dok.kompot.si/s/S4APrLQFd7</a> <a href="https://md.infs.ch/s/Kp6SgGSp4M">https://md.infs.ch/s/Kp6SgGSp4M</a> <a href="https://pad.aleph.world/s/mEuAgw1A7">https://pad.aleph.world/s/mEuAgw1A7</a> <a href="https://doc.neutrinet.be/s/II2BS_Mzje">https://doc.neutrinet.be/s/II2BS_Mzje</a> <a href="https://pad.medialepfade.net/s/HFlOg7BX0">https://pad.medialepfade.net/s/HFlOg7BX0</a> <a href="https://md.eris.cc/s/qVVVD_c-Uo">https://md.eris.cc/s/qVVVD_c-Uo</a> <a href="https://docs.snowdrift.coop/s/PylBpTi_2">https://docs.snowdrift.coop/s/PylBpTi_2</a> <a href="https://notas.laotra.red/s/BT2QHmoxmR">https://notas.laotra.red/s/BT2QHmoxmR</a> <a href="https://md.micronited.de/s/HkzAo5_Gze">https://md.micronited.de/s/HkzAo5_Gze</a> <a href="https://md.giplt.nl/s/2MULa7hrmg">https://md.giplt.nl/s/2MULa7hrmg</a> <a href="https://md.coredump.ch/s/2PVyMqQq_">https://md.coredump.ch/s/2PVyMqQq_</a> <a href="https://hd.wedler.me/s/O3LFyuzM-">https://hd.wedler.me/s/O3LFyuzM-</a> <a href="https://om-office.de/s/SJGJhqdzMl">https://om-office.de/s/SJGJhqdzMl</a> <a href="https://n.jo-so.de/s/ASd2C71b9">https://n.jo-so.de/s/ASd2C71b9</a> <a href="https://pad.medialepfade.net/s/ANRZ-2bXs">https://pad.medialepfade.net/s/ANRZ-2bXs</a> <a href="https://doc.interscalar.eu/s/O_iA5tJJC">https://doc.interscalar.eu/s/O_iA5tJJC</a> <a href="https://pad.yuka.dev/s/0FzortvwIw">https://pad.yuka.dev/s/0FzortvwIw</a> <a href="https://pads.tobast.fr/s/mUblKOiH6b">https://pads.tobast.fr/s/mUblKOiH6b</a> <a href="https://pad.hxx.cz/s/V49wcPLMYM">https://pad.hxx.cz/s/V49wcPLMYM</a> <a href="https://hedgedoc.digilol.net/s/z8K2uXQId-">https://hedgedoc.digilol.net/s/z8K2uXQId-</a> <a href="https://md.sigma2.no/s/T6lGnLkrJ">https://md.sigma2.no/s/T6lGnLkrJ</a> <a href="https://pad.mytga.de/s/4ci4fSilp">https://pad.mytga.de/s/4ci4fSilp</a> <a href="https://hedge.grin.hu/s/JheELmcKCa">https://hedge.grin.hu/s/JheELmcKCa</a> ## The treatment of cardiovascular diseases, Germany ## Heart healthy life full of energy: Specialized treatment of cardiovascular diseases in Germany Your heart deserves the best possible care — and that's exactly what we offer you in Germany. Our modern cardiovascular center brings together highly qualified cardiologists, innovative diagnostic procedures and individualized therapeutic concepts. Why do we treat? Team of experts: Experienced cardiologists and cardiac surgeons with an international reputation are on your side. State of the art diagnostics: We use the latest technology of echocardiography to cardiac‑CT in order to detect their condition accurately. Personalized therapy: Whether pharmacological treatment, catheter intervention or surgery — we develop a tailor-made Plan. Multi-disciplinary approach: Close cooperation between cardiologists, internists, and rehabilitation experts for the best results. Patient-centered care: From the first consultation to aftercare, we will accompany you every step of the way. We treat the following diseases: Coronary heart disease (CHD) Heart rhythm disorders Heart valve defects Heart failure Hypertension with cardiac consequences Prevention of heart attack and stroke Your health is important to us. You don't delay arrange an appointment today for a comprehensive heart health study. Contact us: Phone: +7 (XXX) XXX‑XX‑XX E‑Mail: info@herzzentrum-Germany.ru Website: www.herzzentrum-Germany.ru You can rely on Expertise, Innovation, and warmth your way to a healthier heart begins here, in Germany.